Daily as of 2 Nov 16:00 ET
- Price
- below both $17.85 vs 50 $24.73 / 200 $24.65
- Projection
- 💀Death cross projected in 1 bar
- Test
- No active test
- Last cross
- 🟨Golden cross 26 Sep 2025 · projected 23 bars out
RCUS | Arcus BiosciencesNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$17.85
-$0.34 (-1.87%)
Arcus Biosciences (RCUS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $18.19 vs 50 $24.18 / 200 $17.77
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 25 May 2026 · projected 27 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $18.86 vs 50 $21.87 / 200 $26.51
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 30 Sep 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 30 Sep 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| week of 25 May 2026 | 🟨Golden steep | weekly | 27 bars out | Not tested |
| 22 Apr 2026 | 🟨Golden | 4-hour | 14 bars out | Not tested |
| 15 Apr 2026 | 💀Death | 4-hour | 17 bars out | 1 bar cross test |
| 31 Mar 2026 | 🟨Golden | 4-hour | 3 bars out | 5 bar cross test |
About RCUS
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$35.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmid